FELODIPINE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

felodipine tablet, film coated, extended release

glenmark pharmaceuticals inc., usa - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and with different

FELODIPINE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

felodipine tablet, film coated, extended release

wockhardt usa llc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine extended-release tablets are indicated for the treatment of hypertension. felodipine extended-release tablets may be used alone or concomitantly with other antihypertensive agents. felodipine extended-release tablets are contraindicated in patients who are hypersensitive to this product.

FELODIPINE tablet, extended release United States - English - NLM (National Library of Medicine)

felodipine tablet, extended release

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine extended-release tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic class

SANDOZ FELODIPINE TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

sandoz felodipine tablet (extended-release)

sandoz canada incorporated - felodipine - tablet (extended-release) - 5mg - felodipine 5mg - dihydropyridines